Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice
Citation
S. Bergaya et al., Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice, CIRCUL RES, 88(6), 2001, pp. 593-599
Categorie Soggetti
Cardiovascular & Hematology Research
Journal title
CIRCULATION RESEARCH
SICI code
0009-7330(20010330)88:6<593:DFDICA>2.0.ZU;2-7
Abstract
Flow-dependent dilation is a fundamental mechanism by which large arteries
ensure appropriate blood supply to tissues. We investigated whether or not
the vascular kallikrein-kinin system, especially tissue kallikrein (TK), co
ntributes to flow-dependent dilation by comparing wild-type and TK-knockout
mice in which the presence or absence of TK expression was verified. We ex
amined in vitro changes in the outer diameter of perfused carotid arteries
from TK+/+ and TK-/- mice. In both groups, exogenous bradykinin caused a si
milar dilation that was abolished by the B-2 receptor antagonist HOE-140, a
s well as by the NO synthase inhibitor N-omega-nitro-L-arginine methyl este
r. However, purified kininogen dilated only TK+/+ arteries, demonstrating t
he essential role of TK in the vascular formation of kinins, In TK+/+ arter
ies, increasing intraluminal flow caused a larger endothelium-dependent dil
ation than that seen in TK-/-. both strains the flow response was mediated
by NO and by endothelium-derived hyperpolarizing factor, whereas in TK-/- v
asoconstrictor prostanoids participated as well. HOE-140 impaired flow-depe
ndent dilation in TK+/+ arteries while showing no effect in TK-/-. This com
pound reduced the flow response in TK+/+ arteries to a level similar to tha
t in TK-/-. After NO synthase inhibition, HOE-140 no longer affected the re
sponse of TK+/+. Impaired flow-dependent dilation was also observed in arte
ries from knockout mice lacking bradykinin B-2 receptors as compared with w
ild-type animals. This study demonstrates the active contribution of the va
scular kallikrein-kinin system to one-third of the flow-dependent dilation
response via activation of B-2 receptors coupled to endothelial NO release.